• Saved

A clinical nomogram based on absolute count of lymphocyte subsets for predicting overall survival in patients with non-small cell lung cancer

A clinical nomogram based on absolute count of lymphocyte subsets for predicting overall survival in patients with non-small cell lung cancer

Source : https://www.sciencedirect.com/science/article/pii/S156757692200875X?via=ihub

The higher the absolute count of lymphocyte subsets, the longer the overall survival of the NSCLC patients. * The nomogram constructed by the absolute count of lymphocyte subsets can accurately predict the prognosis of NSCLC patients. * This nomogram provide a more scientific and objective basis for accurate diagnosis and treatment of NSCLC patients.

/>

Conclusions: " We established a prognostic nomogram to predict OS of the NSCLC patient. This nomogram provided a more quantitative, scientific and objective basis for accurate diagnosis and individual management of NSCLC patients."


  • December 30, 2022
    someone would assume that now on patients on clinical trials will need to be radimized based on this nomogram. It would be interesting to see NCCN opinion in this regards